Take Solutions Quarterly Results for Trading Insights

TAKE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹6 Cr
QSept 2025
Quarterly Results

Take Solutions Quarterly Results Key Highlights

  • Revenue of ₹7 Cr in Sept 2025 (+250.0% vs Mar 2025)
  • Net Profit of ₹6 Cr in Sept 2025 (+220.0% vs Mar 2025, +400.0% vs Sept 2024)
  • EBITDA of ₹7 Cr in Sept 2025 (+240.0% vs Mar 2025)
  • Earnings Per Share of ₹0.43 in Sept 2025 (+230.3% vs Mar 2025)

Take Solutions Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 7 2 0 2 0 250.0% -
Net Profit (₹ Cr) 6 -5 -1 1 -2 - -
EBITDA (₹ Cr) 7 -5 -1 1 -1 - -
EPS (₹) 0.43 -0.33 -0.06 0.07 -0.11 - -
Operating Margin (%) 0.0% 0.0% 0.0% 0.0% 0.0% - -

Take Solutions Share Price Trend Around Quarterly Results

Visualize Take Solutions's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Take Solutions

Additional stock information and data for TAKE

Take Solutions share price chart
TAKE price earnings ratio
TAKE 52-week performance

Profitability Ratios

Profit Margin 85.7%
EBITDA Margin 100.0%
ROE (Annual) 114.3%

Balance Sheet Highlights

Total Assets ₹37 Cr
Total Equity ₹21 Cr
Current Assets ₹24 Cr
Current Liabilities ₹0 Cr

Cash Flow Analysis

Operating Cash Flow ₹-16 Cr
Investing Cash Flow ₹22 Cr
Financing Cash Flow ₹-3 Cr
Net Cash Flow ₹3 Cr

Current Market Data

Current Price ₹12.66
Exchange NSE
Last Updated Oct 03, 2025

Revenue Trend (₹ Cr)

Dec 2025 2
Jun 2025 0
Mar 2025 2
Sept 2025 7

Net Profit Trend (₹ Cr)

Dec 2025 1
Jun 2025 -1
Mar 2025 -5
Sept 2025 6

Operating Margin Trend (%)

Dec 2025 0.0%
Jun 2025 0.0%
Mar 2025 0.0%
Sept 2025 0.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Take Solutions quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹430,344.72 Cr 1757.2 14,875 3,125 +10.8% - 21.0% 135.2
Divis Laboratories
Sept 2025 		₹159,214.78 Cr 5947.0 2,860 689 +7.1% - 24.1% 229.0
Torrent Pharmaceuti…
Sept 2025 		₹144,367.29 Cr 4220.2 3,219 591 +11.3% - 18.4% 240.6
Lupin
Sept 2025 		₹107,238.09 Cr 2313.9 6,921 1,485 +23.2% - 21.5% 71.5
Dr Reddys Laborator…
Sept 2025 		₹106,974.57 Cr 1254.9 9,135 1,337 +1.1% - 14.6% 77.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores